Mangoceuticals jumps after partnering with Lilly, Novo Nordisk to sell weight-loss drugs

Mangoceuticals

13/11/2025 12:27

** Shares of telehealth platform Mangoceuticals MGRX.O, also known as MangoRx, rise 35% to $2.33 premarket

** Company says it has partnered with Eli Lilly LLY.N and Novo Nordisk NOVOb.CO to sell the drugmakers' blockbuster weight-loss drugs through its platform

** Co launched MangoRx Direct and PeachesRx Direct programs, through which these branded GLP-1 medications will be made available - MGRX

** As of last close, MGRX down 27.3% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))